Isabelle Fajac
-
- Cystic Fibrosis Research Advances 67
- Neonatal Respiratory Health Research 38
- Tracheal and airway disorders 15
- Inhalation and Respiratory Drug Delivery 8
- Immunology and Allergy top 5%
- Physiology top 10%
- Asthma and respiratory diseases 15
- Genetics top 10%
- Virus-based gene therapy research 8
- Molecular Biology top 10%
- RNA Interference and Gene Delivery 13
-
- Pediatric health and respiratory diseases 4
- Co-authors
- Michel MonsignyGuiti ThévenotD. HubertIsabelle Sermet‐GaudelusPascale BriandK. De BoeckJ LacroniqueY Aron
- Journals
- Annals of Internal Medicine (1 paper)American Journal of Respiratory and Critical Care Medicine (1 paper)Journal of Controlled Release (4 papers)
- Partner nations
- FranceUnited KingdomUnited States
In The Last Decade
Isabelle Fajac
94 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 111
- Pulmonary and Respiratory Medicine 1.1k
- Immunology and Allergy 92
- Physiology 358
- Genetics 336
- Molecular Biology 711
Countries citing papers authored by Isabelle Fajac
This map shows the geographic impact of Isabelle Fajac's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isabelle Fajac with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isabelle Fajac more than expected).
Fields of papers citing papers by Isabelle Fajac
This network shows the impact of papers produced by Isabelle Fajac. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isabelle Fajac. The network helps show where Isabelle Fajac may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Isabelle Fajac, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 6 | |
| 3 | 2024 | 2 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 2 | |
| 6 | 2023 | 7 | |
| 7 | 2020 | 12 | |
| 8 | 2018 | 2 | |
| 9 | Safety, Tolerability and early signs of efficacy with riociguat for the treatment of adult PHE508DEL homozygous cystic fibrosis patients: safety data from the RIO-CF study | 2017 | 1 |
| 10 | 2017 | 39 | |
| 11 | ANALYSIS OF LONG-TERM LIPOSOMAL AMIKACIN FOR INHALATION IN PATIENTS WITH CYSTIC FIBROSIS AND CHRONIC INFECTION FROM PSEUDOMONAS AERUGINOSA | 2014 | 6 |
| 12 | 2013 | 19 | |
| 13 | 2010 | 62 | |
| 14 | 2008 | 28 | |
| 15 | 2004 | 22 | |
| 16 | 2002 | 48 | |
| 17 | 1999 | 30 | |
| 18 | 1996 | 37 | |
| 19 | 1995 | 40 | |
| 20 | 1991 | 78 |
About Isabelle Fajac
Isabelle Fajac is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Emergency Medical Services, having authored 102 papers that have together received 2.1k indexed citations. Recurring topics across this work include Cystic Fibrosis Research Advances (67 papers), Neonatal Respiratory Health Research (38 papers), Tracheal and airway disorders (15 papers), Asthma and respiratory diseases (15 papers), RNA Interference and Gene Delivery (13 papers), Virus-based gene therapy research (8 papers), Inhalation and Respiratory Drug Delivery (8 papers) and Pediatric health and respiratory diseases (4 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (1.1k citations), Immunology and Allergy (92 citations) and Physiology (358 citations). Isabelle Fajac has collaborated with scholars based in France, United Kingdom and United States. Frequent co-authors include Michel Monsigny, Guiti Thévenot, D. Hubert, Isabelle Sermet‐Gaudelus, Pascale Briand, K. De Boeck, J Lacronique, Y Aron, Thierry Bienvenu and Nelly Frossard. Their work appears in journals such as Annals of Internal Medicine, American Journal of Respiratory and Critical Care Medicine and Journal of Controlled Release.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.